What blood test is specific to Hashimoto's thyroiditis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Blood Test Specific to Hashimoto's Thyroiditis

Anti-thyroid peroxidase (anti-TPO) antibodies are the most specific blood test for Hashimoto's thyroiditis, with a sensitivity of 96% and specificity of 100% when using a cutoff of 200 units/ml. 1

Primary Diagnostic Antibodies

Anti-TPO Antibodies (Most Specific)

  • Anti-TPO antibodies are present in 75-96% of patients with histologically confirmed Hashimoto's thyroiditis, making them the primary diagnostic marker 1, 2
  • Using a cutoff of 200 units/ml, anti-TPO testing achieves 96% sensitivity and 100% specificity for Hashimoto's thyroiditis 1
  • Clearly elevated anti-TPO values (>500 units/ml) are found in 59% of Hashimoto's patients but in none of the healthy controls 1
  • The highest frequency of positive anti-TPO results (88%) occurs in patients with autoimmune hypothyroidism (clinical diagnosis: Hashimoto's thyroiditis) 1

Anti-Thyroglobulin Antibodies (Complementary Test)

  • Anti-thyroglobulin (TgAb) antibodies are actually more sensitive than anti-TPO for detecting Hashimoto's thyroiditis in many cases, with prevalence of 96-98.6% versus 73.5-81.4% for anti-TPO 3, 2
  • TgAb by radioimmunoassay is positive in 96.4% of patients with histologically proven Hashimoto's thyroiditis 2
  • In patients with negative conventional hemagglutination tests, TgAb positivity by radioimmunoassay is more closely associated with histological diagnosis of Hashimoto's thyroiditis (89.7%) than TPOAb positivity (27.6%) 2

Recommended Testing Algorithm

Initial Screening

  • Measure both anti-TPO antibodies and anti-thyroglobulin antibodies, as either can be positive in Hashimoto's thyroiditis 2, 4
  • Anti-TPO should be the first-line screening test due to its high specificity, but TgAb should be added when anti-TPO is negative but clinical suspicion remains high 3, 2
  • Thyroid function tests (TSH and free T4) should accompany antibody testing to assess functional status 5

Interpretation of Results

  • Anti-TPO >200 units/ml strongly suggests Hashimoto's thyroiditis with 96% sensitivity and 100% specificity 1
  • Positive anti-TPO antibodies identify an autoimmune etiology and predict higher risk of progression to overt hypothyroidism (4.3% per year versus 2.6% in antibody-negative individuals) 6
  • The combination of elevated TSH with positive anti-TPO antibodies confirms autoimmune hypothyroidism (Hashimoto's thyroiditis) 6

Important Clinical Caveats

Variant Presentations

  • Multinodular Hashimoto's thyroiditis shows lower prevalence of elevated anti-TPO antibodies (36.9%) compared to diffuse Hashimoto's (77.7%), suggesting a variant etiopathogenesis 7
  • In multinodular presentations, the absence of elevated anti-TPO does not exclude Hashimoto's thyroiditis 7

False Positives to Avoid

  • High anti-thyroglobulin antibody concentrations can produce false-positive results in conventional anti-microsomal antibody assays 1
  • Thyroid antibodies are found in the general population at baseline rates, so clinical context is essential for interpretation 5
  • Anti-TPO antibodies can be present in other conditions including Graves' disease (53-80.8% positive) and painless thyroiditis (33%) 3, 1

Testing Method Considerations

  • Radioimmunoassay methods for TgAb and TPOAb are more sensitive than conventional hemagglutination techniques 2, 4
  • Different commercial immunoassay kits show variable performance, with some showing higher TgAb prevalence than TPOAb in Hashimoto's thyroiditis 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.